NEW YORK (Reuters) – Pfizer Inc expects to charge about $110 to $130 per dose for its COVID-19 vaccine after the United States government’s current program expires, Pfizer executive Angela Lukin said on a call with analysts.
Lukin said she expects the vaccine will be made available with no co-pay to people who have private insurance or government paid insurance.
The U.S. government currently provides the vaccine for free to all but pays about $30 per dose to Pfizer and German partner BioNTech SE. In 2023, the market is expected to move to private insurance after the U.S. public health emergency expires.
(Reporting by Michael Erman; Editing by Bill Berkrot)
